Literature DB >> 33765428

Neurodegeneration, Alzheimer's disease biomarkers, and longitudinal verbal learning and memory performance in late middle age.

Samantha L Allison1, Erin M Jonaitis2, Rebecca L Koscik2, Bruce P Hermann2, Kimberly D Mueller3, Robert P Cary4, Yue Ma4, Howard A Rowley5, Cynthia M Carlsson6, Sanjay Asthana1, Henrik Zetterberg7, Kaj Blennow8, Barbara B Bendlin4, Sterling C Johnson9.   

Abstract

This study examined the effect of neurodegeneration, and its interaction with Alzheimer's disease (AD) cerebrospinal fluid biomarkers, on longitudinal verbal learning and memory performance in cognitively unimpaired (CU) late middle-aged adults. Three hundred and forty-two CU adults (cognitive baseline mean age = 58.4), with cerebrospinal fluid and structural MRI, completed 2-10 (median = 5) cognitive assessments. Learning and memory were assessed using the Rey Auditory Verbal Learning Test (RAVLT). We used sequential comparison of nested linear mixed effects models to analyze the data. Model selection preserved a significant ptau181/Aβ42 × global atrophy × age interaction; individuals with less global atrophy and lower ptau181/Aβ42 levels had less learning and delayed recall decline than individuals with more global atrophy and/or higher levels of ptau181/Aβ42. The hippocampal volume × age × ptau181/Aβ42 interaction was not significant. Findings suggest that in a sample of CU late middle-aged adults, individuals with AD biomarkers, global atrophy, or both evidence greater verbal learning and memory decline than individuals without either risk factor. Published by Elsevier Inc.

Entities:  

Keywords:  Cerebrospinal fluid biomarkers; Global atrophy; Hippocampus; Preclinical Alzheimer's disease; Verbal learning; Verbal memory

Mesh:

Substances:

Year:  2021        PMID: 33765428      PMCID: PMC8286465          DOI: 10.1016/j.neurobiolaging.2021.01.030

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   5.133


  66 in total

1.  MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.

Authors:  P Vemuri; H J Wiste; S D Weigand; L M Shaw; J Q Trojanowski; M W Weiner; D S Knopman; R C Petersen; C R Jack
Journal:  Neurology       Date:  2009-07-28       Impact factor: 9.910

2.  ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes.

Authors:  Anja Soldan; Corinne Pettigrew; Anne M Fagan; Suzanne E Schindler; Abhay Moghekar; Christopher Fowler; Qiao-Xin Li; Steven J Collins; Cynthia Carlsson; Sanjay Asthana; Colin L Masters; Sterling Johnson; John C Morris; Marilyn Albert; Alden L Gross
Journal:  Neurology       Date:  2019-03-06       Impact factor: 9.910

3.  Structural MRI changes detectable up to ten years before clinical Alzheimer's disease.

Authors:  Manuela Tondelli; Gordon K Wilcock; Paolo Nichelli; Celeste A De Jager; Mark Jenkinson; Giovanna Zamboni
Journal:  Neurobiol Aging       Date:  2011-07-22       Impact factor: 4.673

4.  CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study.

Authors:  D Strozyk; K Blennow; L R White; L J Launer
Journal:  Neurology       Date:  2003-02-25       Impact factor: 9.910

5.  Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis.

Authors:  Lars Bäckman; Sari Jones; Anna-Karin Berger; Erika Jonsson Laukka; Brent J Small
Journal:  Neuropsychology       Date:  2005-07       Impact factor: 3.295

Review 6.  An approach to studying the neural correlates of reserve.

Authors:  Yaakov Stern
Journal:  Brain Imaging Behav       Date:  2017-04       Impact factor: 3.978

Review 7.  Brain reserve hypothesis in dementia.

Authors:  Laura Fratiglioni; Hui-Xin Wang
Journal:  J Alzheimers Dis       Date:  2007-08       Impact factor: 4.472

8.  Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease.

Authors:  Corinne Pettigrew; Anja Soldan; Kelly Sloane; Qing Cai; Jiangxia Wang; Mei-Cheng Wang; Abhay Moghekar; Michael I Miller; Marilyn Albert
Journal:  Neuroimage Clin       Date:  2017-08-25       Impact factor: 4.881

9.  Differential effects of neurodegeneration biomarkers on subclinical cognitive decline.

Authors:  Andrew P Merluzzi; Nicholas M Vogt; Derek Norton; Erin Jonaitis; Lindsay R Clark; Cynthia M Carlsson; Sterling C Johnson; Sanjay Asthana; Kaj Blennow; Henrik Zetterberg; Barbara B Bendlin
Journal:  Alzheimers Dement (N Y)       Date:  2019-04-12

10.  Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum.

Authors:  Samantha L Allison; Rebecca L Koscik; Robert P Cary; Erin M Jonaitis; Howard A Rowley; Nathaniel A Chin; Henrik Zetterberg; Kaj Blennow; Cynthia M Carlsson; Sanjay Asthana; Barbara B Bendlin; Sterling C Johnson
Journal:  Neuroimage Clin       Date:  2019-06-10       Impact factor: 4.881

View more
  1 in total

1.  Abdominal aortic calcification on lateral spine images captured during bone density testing and late-life dementia risk in older women: A prospective cohort study.

Authors:  Tenielle Porter; Marc Sim; Richard L Prince; John T Schousboe; Catherine Bondonno; Wai H Lim; Kun Zhu; Douglas P Kiel; Jonathan M Hodgson; Simon M Laws; Joshua R Lewis
Journal:  Lancet Reg Health West Pac       Date:  2022-06-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.